Anaergia (ANRG) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jan, 2026Executive summary
Leadership overhaul with new CEO, CFO, General Counsel, and board members, driving a strategic shift to a capital-light model and global expansion.
Q3 2024 marked continued progress in the transition to a capital-light business model, with improved Adjusted EBITDA and reduced net loss despite lower revenues year-over-year.
Completed the final tranche of a $40.8 million equity investment from Marny Investissement SA, strengthening cash position and mitigating prior going concern doubts.
Focus on sustainable, long-term growth and positioning as a leader in renewable energy solutions.
Expansion into key international markets, including a new office in Japan and a contract in Africa.
Financial highlights
Q3 2024 revenue decreased to CAD 29 million from CAD 34 million in Q3 2023, mainly due to completed Italian projects and delayed new signings.
Adjusted EBITDA improved 42% to CAD 6.4 million from CAD 11.1 million in Q3 2023, reflecting operational efficiencies.
Net loss for Q3 2024 was $15.6 million, a 49% improvement from $30.6 million in Q3 2023, driven by lower SG&A and reduced impairments.
Cash position increased to CAD 40.2 million, bolstered by a strategic investment from Mya Energy.
Net SG&A expenses for Q3 2024 decreased 19.2% year-over-year and 21.6% year-to-date.
Outlook and guidance
Growth opportunities are strongest in North America and Europe, with Asia-Pacific and Africa as emerging markets.
2025 expected to be a substantially different year, with positive trends in cash flow and profitability, though no specific guidance on free cash flow timing.
Capital-light strategy and operational discipline to remain central, with a focus on profitable growth and margin improvement.
Management highlighted improved opportunity pipeline, future cash flow projections, and a strengthened cash position as supporting a more stable outlook.
Forward-looking statements caution that actual results may differ due to risks and uncertainties.
Latest events from Anaergia
- Improved margins, major contract wins, and a $103.3M backlog set up strong 2025 growth.ANRG
Q4 202426 Dec 2025 - Backlog rose 94% to CAD 200 million, with improved margins and reduced net loss.ANRG
Q1 202526 Nov 2025 - Revenue up 36.8% and backlog up 137%, with gross margin at 32.5%, signaling strong growth.ANRG
Q2 202523 Nov 2025 - Q3 2025 delivered 77% revenue growth, positive adjusted EBITDA, and a $287M backlog.ANRG
Q3 202517 Nov 2025 - Q2 2024 delivered higher margins and a smaller net loss despite a 45% revenue decline.ANRG
Q2 202413 Jun 2025 - 2023 saw revenue decline, deepening losses, and major restructuring with new strategic investment.ANRG
Q4 202313 Jun 2025 - Revenue declined sharply, but gross profit margin improved on stronger O&M contracts.ANRG
Q1 202413 Jun 2025